Key result
Study protocol outlines assessment of dyslipidemia prevalence and associated factors in Cameroonian type 2 diabetes.
Why the study?
Data describing the burden and determinants of dyslipidemia among type 2 diabetic patients in sub-Saharan Africa remain limited.
Cross-Sectional
No prevalence data reported to inform practice; leaves open dyslipidemia burden and determinants in sub-Saharan African type 2 diabetes.
Objectives: Alterations in lipid metabolism frequently coexist with type 2 diabetes mellitus and substantially contribute to the development of cardiovascular disease. However, data describing the burden and determinants of dyslipidemia among diabetic patients in sub-Saharan Africa remain limited. This study aimed to assess the prevalence of dyslipidemia and identify associated factors among patients with T2DM in Douala, Cameroon.
No takes yet. Share an insight, caveat, or question.
Dakam et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus. Associated risk factors was evaluated on Prevalence of dyslipidemia and associated factors. The provided abstract outlines the objective to assess dyslipidemia prevalence and contributing factors in type 2 diabetic patients in Cameroon, but reports no quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: